|
Huber, S A; Moraska, A (1992) Cytolytic T lymphocytes and antibodies to myocytes in adriamycin-treated BALB/c mice. Evidence for immunity to drug-induced antigens. Am J Pathol 140:233-42
|
|
Van Houten, N; Huber, S A (1991) Genetics of Coxsackie B3 (CVB3) myocarditis. Eur Heart J 12 Suppl D:108-12
|
|
Weremeichik, H; Moraska, A; Herzum, M et al. (1991) Naturally occurring anti-idiotypic antibodies--mechanisms for autoimmunity and immunoregulation? Eur Heart J 12 Suppl D:154-7
|
|
Van Houten, N; Bouchard, P E; Moraska, A et al. (1991) Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen. J Virol 65:1286-90
|
|
Craighead, J E; Huber, S A; Sriram, S (1990) Animal models of picornavirus-induced autoimmune disease: their possible relevance to human disease. Lab Invest 63:432-46
|
|
Huber, S A; Haisch, C; Lodge, P A (1990) Functional diversity in vascular endothelial cells: role in coxsackievirus tropism. J Virol 64:4516-22
|
|
Huber, S A (1990) Doxorubicin-induced alterations in cultured myocardial cells stimulate cytolytic T lymphocyte responses. Am J Pathol 137:449-56
|
|
Weller, A H; Simpson, K; Herzum, M et al. (1989) Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis. J Immunol 143:1843-50
|
|
Blay, R; Simpson, K; Leslie, K et al. (1989) Coxsackievirus-induced disease. CD4+ cells initiate both myocarditis and pancreatitis in DBA/2 mice. Am J Pathol 135:899-907
|
